PFCS
ABEO icon

Pale Fire Capital SE’s Abeona Therapeutics ABEO Stock Holding History

Pale Fire Capital SE’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Sell
69,845
-104,860
-60% -$524K 0.03% 44
2025
Q4 		$921K Buy
+174,705
New +$879K 0.06% 33

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pale Fire Capital SE's ABEO Position: Q1 2026 in Review

Pale Fire Capital SE reduced its Abeona Therapeutics (ABEO) stake by 60% in Q1 2026, selling an estimated $524K and leaving 69,845 shares worth $313K. The position accounts for 0.03% of the portfolio, ranked #44.

Pale Fire Capital SE first reported a position in ABEO in Q4 2025 and has held it in 2 quarters since. The position peaked at $921K in Q4 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Pale Fire Capital SE held 69,845 shares of Abeona Therapeutics worth $313K as of Q1 2026.
  • Pale Fire Capital SE sold 104,860 Abeona Therapeutics shares in Q1 2026, an estimated $524K.
  • Abeona Therapeutics made up 0.03% of Pale Fire Capital SE's portfolio in Q1 2026, its #44 holding.
  • Pale Fire Capital SE first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Pale Fire Capital SE's Abeona Therapeutics position peaked at $921K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.